Sinus Infection
Read MoreSinus infection is a major health problem. It afflicts 31 million people in the United States.
Seasonal Allergies
Read MoreSeasonal allergies, like other types of allergies, develop when the body’s immune system overreacts to something in the environment, usually during spring, sum…
Rinosinusitis Crónica Con Pólipos Nasales
Read MoreCon el respaldo de Sanofi RegeneronPólipos NasalesLa rinosinusitis crónica con pólipos nasales es una afección que puede provocar síntomas desagradables, desde…
Ragweed Allergy
Read MoreThe pollen from ragweed causes allergy symptoms in many people. These symptoms include sneezing, runny or stuffy nose, and itchy throat.
Pollen Allergies
Read MorePollens and molds can cause allergy and asthma symptoms, and you need to know what you’re allergic to so you can best treat your symptoms.
Pine Tree "Allergy"
Read MoreWhile pine tree allergy is relatively uncommon, there are two main allergens of concern that come from pine trees.
Pet Allergies
Read MoreIf your nose runs, your eyes water or you start sneezing and wheezing after petting or playing with a dog or cat, you likely have a pet allergy.
Mold Allergies
Read MoreMolds live everywhere—on logs and on fallen leaves, and in moist places like bathrooms and kitchens. Some people are allergic to these molds. An allergy occurs…
Latex Allergy
Read MoreAllergic reactions to latex may be serious and can very rarely be fatal. If you have latex allergy you should limit or avoid future exposure to latex products.
Insect Sting Allergies
Read MoreStings from five insects - honeybees, hornets, wasps, yellow jackets and fire ants - are known to cause allergic reactions to the venom injected into the skin.
Milk & Dairy
Read MoreMilk: It’s good for your health and good for bone strength. It’s also one of the most common food allergens, particularly in children.
Food Protein-Induced Enterocolitis Syndrome (FPIES)
Read MoreFood protein-induced enterocolitis syndrome (FPIES) is a type of gastrointestinal food allergy that affects mostly infants and young children.
Food Allergy
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
Eye Allergy
Read MoreIf your eyes itch and are red, tearing or burning, you may have eye allergies (allergic conjunctivitis), a condition that affects millions of Americans. Many p…
COVID-19 Federal Responses: Monday, February 14, 2022
Read MoreA study found that the effectiveness of booster shots wanes over time. Effectiveness against hospitalization fell from 91% two months post-booster to 78% at four months. The Occupational Safety and Health Administration (OSHA) continues to develop permanent COVID-19 safety standards. Pfizer postponed…
COVID-19 Federal Responses: Thursday, February 3, 2022
Read MoreA study into the infection dynamics of the original strain of COVID-19 conducted on unvaccinated adults found that the incubation period averaged only 46 hours, shorter than current estimate of 5 to 6 days. A study on why some people are more susceptible…
COVID-19 Federal Responses: Monday, January 31, 2022
Read MoreVirologists suggest that individuals who receive positive test results from rapid antigen tests are likely still contagious, even if that test is taken after the five-day isolation period from onset of symptoms recommended by federal guidelines. A new study suggests that pulse oximetry…
COVID-19 Federal Responses: Thursday, January 27, 2022
Read MoreA CDC study found that children who contracted COVID-19 were more likely to be diagnosed with diabetes than those who were previously diagnosed with other respiratory infections. The head of the World Health Organization (WHO) warned against assuming the Omicron variant represents the…
COVID-19 Federal Responses: Monday, January 24, 2022
Read MorePfizer’s CEO predicts people will receive annual COVID-19 vaccines. The CDC updated its website and guidelines including Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2 and Strategies to Mitigate Healthcare Personnel Staffing Shortages…
COVID-19 Federal Responses: Thursday, January 20, 2022
Read MoreThe Centers for Disease Control and Prevention (CDC) updated their guidance to recommend N95 masks to Americans to help alleviate the spread of COVID-19. The government will distribute 400 million free N95 masks by the beginning of February to pharmacies and health centers…
COVID-19 Federal Responses: Thursday, January 13, 2022
Read MoreThe National Institutes of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci predicts that “just about everybody” will be infected with COVID-19 due to the Omicron variant. The Biden Administration increased its order for at-home COVID-19 tests from 500 million…
COVID-19 Federal Responses: Thursday, December 23, 2021
Read MorePfizer says the two-dose COVID-19 vaccine regimen it tested on children did not consistently provide sufficient immune response in children between the ages two and five. However, the regimen was more effective for children between the ages of six months and two…
COVID-19 Federal Responses: Thursday, December 16, 2021
Read MoreNew research shows that COVID-19 infection poses a greater risk of myocarditis than the vaccines. The CDC’s ACIP issued a new recommendation for the MRNA vaccines over the J&J vaccine, due to the blood clotting risks associated with the J&J…
AllergyWatch
Read MoreWith AllergyWatch, the College has done the work for you: We’ve collected relevant specialty news from around the world in a… With AllergyWatch, the College has done the work for you: We’ve collected relevant specialty news from around the world in a single bimonthly publication. AllergyWatch gives you…
COVID-19 Federal Responses: Monday, December 6, 2021
Read MoreThe National Institutes of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci said preliminary information about the Omicron variant shows it might not cause as severe disease as frequently as expected. However, more data is needed to confirm this information. Even though the…
COVID-19 Federal Responses: Thursday, December 2, 2021
Read MoreWhite House COVID-19 Response Coordinator, Jeff Zients said the United States (U.S.) is not planning new lockdowns at this time despite many countries in Europe re-imposing lockdowns to combat new surges in COVID-19 infections. A new study shows that receiving…
AllergyWatch Archives
Read MoreSupported by: 2022 Access AllergyWatch archives for Volume 24. Each issue is available to download as a pdf. Vol. 24,… Supported by: 2022Access AllergyWatch archives for Volume 24. Each issue is available to download as a pdf.Vol. 24, No. 1 (Jan/Feb)Vol. 24, No. 2 (Mar/Apr)Vol.…
Latest Issue of AllergyWatch
in AllergyWatchRead MoreOnline exclusive: A synopsis of allergy and asthma literature, resulting from an unbiased, comprehensive review of 20 major medical… Online exclusive: A synopsis of allergy and asthma literature, resulting from an unbiased, comprehensive review of 20 major medical journals.…
COVID-19 Federal Responses: Thursday, November 18, 2021
Read MoreThe Mayo Clinic reported that monoclonal antibodies reduced the risk of COVID-19 hospitalization by 77%. The Centers for Medicare and Medicaid Services (CMS) is offering individual clinicians an exemption from Merit-based Incentive Payment System (MIPS) reporting for 2021 due to hardships caused…
COVID-19 Federal Responses: Monday, November 15, 2021
Read MoreAn appeals court opinion said the federal vaccine mandate for large employers is flawed. This legal challenge temporarily stops the mandate from taking effect while the legal challenge plays out. However, the mandate does not take effect until January 4. The Biden Administration announced…
COVID-19 Federal Responses: Monday, October 18, 2021
Read MoreBeginning next week, states can order COVID-19 vaccines in preparation for efforts to vaccinate children ages 5-11. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend Emergency Use Authorization (EUA) of the Johnson & Johnson booster vaccine…
COVID-19 Federal Responses: Monday, October 4, 2021
Read MoreThe European Medicines Agency (EMA), the European Union's drug regulator, recently discovered a possible link between the Johnson & Johnson vaccine and rare blood clotting (venous thromboembolism). J&J will seek FDA authorization of their COVID-19 booster vaccine. An updated Kaiser Family Foundation…
COVID-19 Federal Responses: Monday, November 29, 2021
Read MoreModerna, Pfizer and Johnson & Johnson announced that they have all begun working on Omicron-specific COVID-19 vaccine boosters that should be ready in early 2022. Omicron has not been detected in the U.S., although National Institute of Allergy and Infectious Diseases (NIAID…
AllergyTalk Podcast
Read MoreAllergyTalk features conversations about the latest research and hot topics in the field of allergy and immunology by the American… AllergyTalk features conversations about the latest research and hot topics in the field of allergy and immunology by the American College of Allergy, Asthma and…
Making RVUs Work for You
Course Opens: | Course Expires:Read MorePrice: FREE to College members, $25 non-membersRelative Value Units (RVUs) are very important to the success of your practice; they define the value of a service or procedure relative to all services and procedures. Learn more about how they can be used to benefit…
MicroCME: FPIES - Prevalence, Diagnosis and Management Pearls
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 22 minutesThis microlearning discusses the prevalence, diagnosis and management of Food Protein-Induced Enterocolitis Syndrome (FPIES).AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing…
MicroCME: Alterations in the Microbiome in Patients With Food Allergies
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 22 minutesThis microlearning discusses how the microbiome is altered in patients with food allergies, and reviews the evidence regarding use of targeted treatment for food allergy prevention or treatment.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is…
MicroCME: Practice Parameter - Diagnostic Testing for Peanut Allergy
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 29 minutesThis microlearning discusses the state of peanut allergy testing and evidence surrounding diagnostic testing for peanut allergy.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to…
MicroCME: FDA-Approved Oral Immunotherapy
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 21 minutesThis microlearning discusses the current state of FDA-approved oral immunotherapy.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians…
MicroCME: The Changing Paradigm of Telemedicine
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 20 minutesThis microlearning discusses the changing paradigm of telemedicine.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.DesignationThe American College…
MicroCME: Coding Update
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 21 minutesThis microlearning discusses the general requirements of coding; changes in coding for 2021; and where to find changes and answers.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical…
MicroCME: Evaluating a Patient With Elevated Peripheral Eosinophilia
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 23 minutesThis microlearning discusses the differential diagnosis, evaluation and treatment for patients with peripheral eosinophilia.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical…
MicroCME: Dermatitis in Skin of Color
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 23 minutesThis microlearning discusses how to identify, manage and treat dermatitis in patients from different races.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing…
MicroCME: Evaluation and Management of Adverse Reactions to Vaccines
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 23 minutesThis microlearning discusses vaccine-related adverse effects, including allergic reactions, and how to evaluate and manage them.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to…
MicroCME: Chronic Rhinosinusitis: Today's Surgical Options and Outcomes
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 35 minutesThis microlearning discusses current surgical options and outcomes in treatment of Chronic Rhinosinusitis (CRS).AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical…
MicroCME: Emerging Therapies for Refractory Urticaria
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 23 minutesThis microlearning course discusses emerging therapy options to treat refractory urticaria.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians…
MicroCME: Beyond OIT: How Biologics Can Help Patients With Food Allergy
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 24 minutesThis microlearning discusses the the role of biologics in food allergy patients.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for…
MicroCME: Eosinophilic Esophagitis
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 33 minutesThis microlearning provides an update on current guidelines regarding diagnosis and management options, including use of shared decision-making to help patients decide between dietary elimination and/or medical management.AccreditationThe American College of Allergy, Asthma & Immunology…
MicroCME: SCIT or SLIT: No One Option Is Perfect - A Role for Shared Decision-making
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 32 minutesThis microlearning discusses shared decision-making when considering SCIT versus SLIT therapy.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for…
MicroCME: Ongoing Avoidance Without Treatment
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 16 minutesThis microlearning discusses FDA-approved immunotherapy, epicutaneous immunotherapy, and ongoing avoidance without treatmentAccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for…
MicroCME: Biomarker Interpretations and How This Would Aid in Treatment Choice and Prognosis Prediction
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 25 minutesThis microlearning discusses biomarker Interpretations and how this would aid in treatment choice and prognosis prediction.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide…
MicroCME: Chronic Rhinosinusitis: Causes, Contributing Factors and Evaluation of the Patient
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 37 minutesThis microlearning discusses the causes, factors and evaluation of patients with Chronic Rhinosinusitis (CRS).AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical…
MicroCME: Anaphylaxis
Course Opens: | Course Expires:Read MorePrice: FREE to members; $10 non-membersLength: 13 minutesThis microlearning course discusses key updates on pediatric anaphylaxis.AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.DesignationThe American…
MicroCME: Do Patients Receiving Subcutaneous Immunotherapy Need To Have an Epinephrine Auto-injector Prescribed?
Course Opens: | Course Expires:Read MorePrice: FREE to members; $20 non-membersLength: 32 minutesThis microlearning discusses the need for patients receiving SCIT to be prescribed an epinephrine auto-injector..AccreditationThe American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide…
Abstract Submission FAQs
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
Attendee Service Center
Read MoreAttendee Service Center Please Sign InLast Name: Member Number: Forgot Password? …
Epinephrine Auto-injector
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
CAP (Continuous Assessment Program) Review | ACAAI Annual Scientific Meeting 2021
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
- Read More
An allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
Future Meeting Dates | ACAAI Annual Scientific Meeting 2019
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
Is it possible to be allergic to a dye in a food?
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
Plan to Attend | ACAAI Annual Meeting 2021
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
- Read More
An allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
PMP - Practice Management Program | ACAAI Annual Scientific Meeting 2021
Read MoreAn allergy occurs when your body’s natural defenses overreact to exposure to a particular substance, treating it as an invader and sending out chemicals to def…
